Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CEO & President

Chief Financial Officer

Chief Accounting Officer

See remarks

Chief Executive Officer

Executive Chairman

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases in the United States and Europe. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion protein N-803, vaccine technologies, toll-Like receptor activating adjuvants, natural killer cells, and damage-associated molecular patterns inducers. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute and Amyris, Inc.; and license agreements with LadRx Corporation, GlobeImmune, Inc., Access to Advanced Health Institute, 3M Innovative Properties Company, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company is based in San Diego, California.

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement, harness, and ampl...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-05	Premium	sold (taxes)	Premium	Premium	Premium	CEO & President
2024-02-05	Premium	acquired	Premium	Premium	Premium	CEO & President
2024-01-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-31	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-01-31	Premium	acquired	Premium	Premium	Premium	-
2024-01-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-12-31	Premium	acquired	Premium	Premium	Premium	CEO & President
2023-12-31	Premium	sold (taxes)	Premium	Premium	Premium	CEO & President
2023-12-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-12-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-12-15	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-09-11	Premium	acquired	Premium	Premium	Premium	See remarks
2023-09-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-09-01	Premium	acquired	Premium	Premium	Premium	-
2023-09-01	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-06-15	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-06-05	Premium	bought	Premium	Premium	Premium	-
2023-06-02	Premium	bought	Premium	Premium	Premium	-
2023-06-01	Premium	bought	Premium	Premium	Premium	-
2023-02-05	Premium	sold (taxes)	Premium	Premium	Premium	CEO & President
2023-02-05	Premium	acquired	Premium	Premium	Premium	CEO & President
2022-12-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-12-31	Premium	sold (taxes)	Premium	Premium	Premium	CEO & President

IBRX - ImmunityBio, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for IBRX